29 August 2022Greenfern eyes FDA-approved cannabinoid medicine opportunity as part of multi dealPatients in New Zealand, Australia and the Pacific Islands could soon have access to Syndros, one of only four Food and ...Read More
25 August 2022Cannasouth Cultivation Facility Achieves GACP CertificationCannasouth Limited (NZX:CBD) is pleased to announce that its subsidiary, Cannasouth Cultivation Limited, has today received it’s Good Agricultural and Collection ...Read More
15 August 2022Greenfern remains NZ’s only Toitū net carbonzero medicinal cannabis company, recertified againGreenfern Industries continues to lead the way both locally and internationally, having been certified a Toitū net carbonzero organisation for the ...Read More
9 August 2022Cannabinoids could provide relief from neuropathic painA three-year neuropathic pain (pre-clinical) study by Cannasouth has confirmed that cannabinoids from medicinal cannabis could be effective at reducing debilitating ...Read More